Gadofullerenes and gadonanotubes: A new paradigm for high-performance magnetic resonance imaging contrast agent probes

Journal of Biomedical Nanotechnology

Volumn 3, Issue 4, 2007, Pages 342-352

  Sitharaman, Balaji ^a   Wilson, Lon J ^a  

^a RICE UNIVERSITY   (United States)

Author keywords

Biomedical applications; Contrast agents; Gadofullerenes; Gadonano tubes; Gd 60; Magnetic Resonance Imaging (MRI); Molecular imaging; NMRD; Single walled carbon nanotube; US Tubes

Indexed keywords

CARBON NANOTUBE; CONTRAST MEDIUM; FULLERENE DERIVATIVE; GADOFULLERENE DERIVATIVE; GADOLINIUM; GADOLINIUM CHELATE; GADOLINIUM PENTETATE; GADONANOTUBE; SINGLE WALLED NANOTUBE; TRIENTINE;

BIOMEDICAL TECHNOLOGY ASSESSMENT; CYTOTOXICITY; DIAGNOSTIC VALUE; DRUG STRUCTURE; HYDROPHOBICITY; HYPERTHERMIA; IMAGING SYSTEM; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR IMAGING; MOLECULAR PROBE; NANOTECHNOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PH; PHYSICAL CHEMISTRY; REVIEW; SENSITIVITY AND SPECIFICITY; SOLID TUMOR; TEMPERATURE;

EID: 45849099836     PISSN: 15507033     EISSN: 15507041     Source Type: Journal    
DOI: 10.1166/jbn.2007.043     Document Type: Review

References (59)

1. P. Mansfield, Snapshot magnetic resonance imaging. Angew. Chem. Int. Ed. 43, 5456 (2004).
2. R. B. Lauffer, Paramagnetic metal complexes as water proton relaxation agents for NMR imaging: Theory and design. Chem. Rev. 87, 901 ( 1987).
3. A. E. Merbach, E. Toth, and L. Helm (eds.), The Chemistry of Contrast Agents in Medical Magnetic Resonance Imaging, John Wiley & Sons, New York (2001).
4. W. Krause (ed.), Topics in Current Chemistry 221, Contrast Agents I: Magnetic Resonance Imaging, Springer-Verlag, New York (2002).
5. P. Caravan, J. J. Ellison, T. J. McMurry, and R. B. Lauffer, Gadolinium(III) chelates as MRI contrast agents: Structure, dynamics, and applications. Chem. Rev. 99, 2293 (1999).
6. A. D. Nunn, K. E. Linder, and M. F. Tweedle, Can receptors be imaged with MRI agents. Quart. J. Nucl. Med. 41, 155 (1997).
7. N. Tagmatarchis and H. Shinohara, Fullerenes in medicinal chemistry and their biological applications. Mini Rev. Med. Chem. 1, 339 ( 2001).
8. E. Brücher, Kinetic stabilities of Gadolinium(III) chelates used as MRI contrast agents. Top. Curr. Chem. 221, 103 (2002).
9. L. L. Dugan, D. M. Turetsky, C. Du, D. Lobner, M. Wheeler, C. R. Almli, C. Shen, T. Luh, D. Choi, and T. Lin, Carboxyfullerenes as neuroprotective antioxidants. Proc. Natl. Acad. Sci. USA 94, 9434 (1997).
10. 60 by human monocyte macrophages, its localization and implications for toxicity: Studied by high resolution electron microscopy and electron tomography. Acta Biomaterialia 2, 409 ( 2006).
11. S. A. Anderson, K. K. Lee, and J. A. Frank, Gadolinium-fullerenol as a paramagnetic contrast agent for cellular imaging. Investigative Radiology 41, 332 (2006).
12. B. Sitharaman, L. A. Tran, R. D. Bolskar, R. Muthupillai, S. D. Flamm, A. G. Mikos, and L. J. Wilson, Gadofullerenes as nanoscale magnetic labels for cellular magnetic resonance imaging. Contrast Media & Molecular Imaging 2, 139 (2007).
13. D. Pantarotto, J.-P. Briand, M. Prato, and A. Bianco, Translocation of bioactive peptides across cell membranes by carbon nanotubes. Chem. Commun. 1, 16 (2004).
14. N. W. S. Kam, T. C. Jessop, P. A. Wender, and H. Dai, Nanotube molecular transporters: Internalization of carbon nanotube-protein conjugates into mammalian cells. J. Am. Chem. Soc. 126, 6850 (2004).
15. Q. Lu, J. M. Moore, G. Huang, A. S. Mount, A. M. Rao, L. L. Larcom, and P. C. Ke, RNA polymer translocation with single-walled carbon nanotubes. Nano Lett. 4, 2473 (2004).
16. M. Mikawa, H. Kato, M. Okumura, M. Narazaki, Y. Kanazawa, N. Miwa, and H. Shinohara, Paramagnetic water-soluble metallofullerene having the highest relaxivity for MRI contrast agents. Bioconj. Chem. 12, 510 (2001).
17. 10 as a MRI contrast agent. J. Am. Chem. Soc. 125, 5471 (2003).
18. S. Stevenson, G. Rice, T. Glass, K. Harlch, E Cromer, M. R. Jordan, J. Craft, E. Hadju, R. Bible, M. M. Olmstead, K. Maltra, A. J. Fisher, A. L. Balch, and H. C. Dorn, Small-bandgap endohedral metallofullerenes in high yield and purity. Nature 401, 55 (1999).
19. P. P. Fatouros, F. D. Frank, Z. Chen, W. C. Broaddus, J. L. Tatum, B. Kettenmann, Z. Ge, H. W. Gibson, J. L. Russ, A. P. Leonard, J. C. Duchamp, and H. C. Dorn, In vitro and in vivo imaging studies of a new endohedral metallofullerene nanoparticle. Radiology 240, 756 (2006).
20. L. J. Wilson, Medical applications of fullerenes and metallofullerenes. Electrochem. Soc. Interface 8, 24 (1999).
21. H. Kato, Y. Kanazawa, M. Okumura, A. Taninaka, T. Yokawa, and H. Shinohara, Lanthanoid endohedral metallofullerenols for MRI contrast agents. J. Am. Chem. Soc. 125, 4391 (2003).
22. H. Shinohara, Endohedral metallofullerenes. Rep. Prog. Phys. 63, 843 (2000).
23. N. Bloembergen, E. M. Purcell, and R. V. Pound, Relaxation effects in nuclear magnetic resonance absorption. Phys. Rev. 73, 679 (1948).
24. I. Solomon, Relaxation processes in a system of two spins. Phys. Rev. 99, 559 (1955).
25. I. Solomon and N. Bloembergen, Nuclear magnetic interactions in the HF molecule. J. Chem. Phys. 25, 261 (1956).
26. N. Bloembergen, Proton relaxation times in paramagnetic solutions. J. Chem. Phys. 27, 572 (1957).
27. N. Bloembergen and L. O. Morgan, Proton relaxation times in paramagnetic solutions. Effects of electron spin relaxation. J. Chem. Phys. 34, 842 (1961).
28. R. E. Connick and D. J. Fiat, Oxygen-17 nuclear magnetic resonance study of the hydration shell of nickelous ion. J. Chem. Phys. 44, 4103 (1966).
29. J. Kowalewski, Encyclopedia of Nuclear Magnetic Resonance, John Wiley and Sons (1996), pp. 3456-3462.
30. E. Toth, R. D. Bolskar, A. Borel, G. Gonzalez, L. Helm, A. E. Merbach, B. Sitharaman, and L. J. Wilson, Water-soluble gadofullerenes: Toward high-relaxivity, pH-responsive MRI contrast agents. J. Am. Chem. Soc. 127, 799 (2005).
31. - related to NMR imaging. Inorg. Chem. 32, 3844 (1993).
32. x: Nanoscale aggregation studies of two metallofullerene MRI contrast agents in aqueous solution. Nano Lett. 4, 2373 (2004).
33. 10. J. Am. Chem. Soc. (2005), submitted.
34. S. Laus, B. Sitharaman, E. Toth, R. D. Bolskar, L. Helm, L. J. Wilson, and A. E. Merbach, Understanding paramagnetic relaxation phenomena for water-soluble gadofullerenes. J. Phys. Chem. C 111, 5633 (2007).
35. P. M. May, P. W. Linder, and D. R. Williams, Computer simulation of metal-ion equilibria in biofluids: Models for the low-molecular-weight complex distribution of calcium(II), magnesium(II), manganese(II), iron(III), copper(II), zinc(II), and lead(II) ions in blood plasma. J. Chem. Soc., Dalton Trans. 6, 588 (1977).
36. C. R. Martin and P. Kohli, The emerging field of nanotube biotechnology. Nat. Rev. Drug Discovery 2, 29 (2003).
37. Z. Gu, H. Peng, R. H. Hauge, R. E. Smalley, and J. L. Margrave, Cutting single-wall carbon nanotubes through fluorination. Nano Lett. 2, 1009 (2002).
38. Y. A. Mackeyev, J. W. Marks, M. G. Rosenblum, and L. J. Wilson, Stable containment of radionuclides on the nanoscale by cut single-wall carbon nanotubes. J. Phys. Chem. B 109, 5482 (2005).
39. K. Suenaga, M. Tence, C. Mory, C. Colliex, H. Kato, T. Okazaki, H. Shinohara, K. Hirahara, S. Bandow, and S. Lijima, Element-selective single atom imaging. Science 290, 2280 (2000).
40. B. Sitharaman, K. R. Kissell, K. B. Hartman, L. A. Tran, A. Baikalov, I. Rusakova, Y. Sun, H. A. Khant, S. J. Ludtke, W. Chiu, S. Laus, É. Tóth, L. Helm, A. E. Merbach, and L. J. Wilson, Superparamagnetic gadonanotubes are high-performance MRI contrast agents. Chem. Commun. 3915 (2005).
41. 2-loaded SWNTs. J. Phys. Chem. B 110, 17425 (2006).
42. 211AtClΥS-tube nanocapsules: A new concept in radiotherapeutic-agent design. Small 3, 1496 (2007).
43. M. R. McDevitt, D. Chattopadhyay, B. J. Kappel, J. S. Jaggi, S. R. Schiffman, C. Antczak, J. T. Njardarson, R. Brentjens, and D. A. Scheinberg, Tumor targeting with antibody-functionalized, radiolabeled carbon nanotubes. J. Nucl. Med. 48, 1180 (2007).
44. B. Sitharaman and L. J. Wilson, Gadonanotubes as new high-performance MRI contrast agents. International Journal of Nanomedicine 1, 291 (2006).
45. R. McDermott, S. Lee, B. ten Haken, A. H. Trabesinger, A. Pines, and J. Clarke, Microtesla MRI with a superconducting quantum interference device. Proc. Natl. Acad. Sci. USA 101, 7857 (2004).
46. G. Hummer, J. C. Rasalah, and J. P. Noworyta, Water conduction through the hydrophobic channel of a carbon nanotube. Nature 414, 188 ( 2001).
47. F. Zhu and K. Schulten, Water and proton conduction through carbon nanotubes as models for biological channels. Biophys. J. 85, 236 (2003).
48. W. H. Noon, K. D. Ausman, R. E. Smalley, and J. Ma, Helical ice-sheets inside carbon nanotubes in the physiological condition. Chem. Phys. Lett. 355, 445 (2002).
49. R. J. Mashl, S. Joseph, N. R. Aluru, and E. Jakobsson, Anomalously immobilized water: A new water phase induced by confinement in nanotubes. Nano Lett. 3, 589 (2003).
50. C. Dellago, M. M. Naor, and G. Hummer, Proton transport through water-filled carbon nanotubes. Phys. Rev. Lett. 90, 105902/1 ( 2003).
51. D. J. Mann and M. D. Halls, Water alignment and proton conduction inside carbon nanotubes. Phys. Rev. Lett. 90, 195503/1 (2003).
52. J. Hall, R. Haner, S. Aime, M. Botta, S. Faulkner, D. Parker, and A. S. de Sousa, Relaxometric and luminescence behaviour of triaquahexaazamacrocyclic complexes, the gadolinium complex displaying a high relaxivity with a pronounced pH dependence. New J. Chem. 627, (1998).
53. 3+-loaded polyion complex for pH depiction with magnetic resonance imaging. J. Biomed. Mater. Res. 49, 390 (2000).
54. I. F. Tannock and D. Rotin, Acid pH in tumors and its potential for therapeutic exploitation. Cancer Res. 49, 4373 (1989).
55. J. L. Wike-Hooley, J. Haveman, and H. S. Reinhold, The relevance of tumour pH to the treatment of malignant disease. Radiother. Oncol. 2, 343 (1984).
56. M. Stubbs, P. M. J. McSheehy, J. R. Griffiths, and C. L. Bashford, Tumour pH - causes and consequences of tumour acidity and implications for treatment. Molecular Medicine Today 6, 15 (2000).
57. P. Caravan, N. J. Cloutier, M. T. Greenfield, S. A. McDermid, S. U. Dunham, J. W. M. Bulte, J. C. J. Amedio, R. J. Looby, R. M. Supkowski, W. D. J. Horrocks, T. J. McMurry, and R. B. Lauffer, The interaction of MS-325 with human serum albumin and its effect on proton relaxation rates. J. Am. Chem. Soc. 124, 3152 (2002).
58. P. Moroz, S. K. Jones, and B. N. Gray, Magnetically mediated hyperthermia: Current status and future direction. Internation Journal of Hyperthermia: Official Journal of European Society for Hyperthermic Oncology. North American Hyperthermia Group 18, 267 ( 2002).
59. R. E. Rosensweig, Heating magnetic fluid with alternating magnetic field. J. Magn. Magn. Mater. 252, 370 (2002).